PROS1 and infection: In this study, we demonstrated that SARS-CoV-2 mRNA vaccines, encoding the full-length S protein, might trigger the cellular response to other viral proteins in individuals with past infection or infection-naïve individuals with previous cross-reactivity, although the contribution of these responses to the control of infection is still under investigation.